Platform
Features
Stemline Therapeutics
Contact
No bio yet
Ken Hoberman
Chief Operating Officer
Sign up to view 7 direct reports
Get started
23 members
Ad
Fios Genomics
Amneal Pharmaceuticals
TOLREMO therapeutics
Quantoom Biosciences
Institute for Protein Innovation